A detailed history of Vanguard Group Inc transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Vanguard Group Inc holds 7,052,570 shares of TNDM stock, worth $284 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,052,570
Previous 7,021,906 0.44%
Holding current value
$284 Million
Previous $208 Million 20.23%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$22.09 - $35.41 $677,367 - $1.09 Million
30,664 Added 0.44%
7,052,570 $250 Million
Q4 2023

Feb 14, 2024

BUY
$14.28 - $31.03 $265,193 - $576,258
18,571 Added 0.27%
7,021,906 $208 Million
Q3 2023

Nov 14, 2023

SELL
$19.33 - $36.22 $184,949 - $346,552
-9,568 Reduced 0.14%
7,003,335 $145 Million
Q2 2023

Aug 14, 2023

SELL
$24.18 - $42.46 $835,999 - $1.47 Million
-34,574 Reduced 0.49%
7,012,903 $172 Million
Q1 2023

May 15, 2023

BUY
$35.86 - $46.5 $33 Million - $42.8 Million
920,248 Added 15.02%
7,047,477 $286 Million
Q4 2022

Feb 10, 2023

SELL
$35.49 - $56.15 $2.38 Million - $3.76 Million
-67,047 Reduced 1.08%
6,127,229 $275 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $68.97 $7.85 Million - $12.4 Million
-179,317 Reduced 2.81%
6,194,276 $296 Million
Q2 2022

Aug 12, 2022

BUY
$53.22 - $123.09 $3.56 Million - $8.23 Million
66,869 Added 1.06%
6,373,593 $377 Million
Q1 2022

May 13, 2022

BUY
$101.89 - $150.09 $14.9 Million - $22 Million
146,577 Added 2.38%
6,306,724 $733 Million
Q4 2021

Feb 14, 2022

BUY
$118.18 - $153.21 $12.9 Million - $16.7 Million
109,088 Added 1.8%
6,160,147 $927 Million
Q3 2021

Nov 12, 2021

BUY
$93.51 - $129.4 $41.8 Million - $57.8 Million
446,554 Added 7.97%
6,051,059 $722 Million
Q2 2021

Aug 13, 2021

BUY
$77.0 - $100.19 $432 Million - $562 Million
5,604,505 New
5,604,505 $546 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.59B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.